Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00388089 · COMPLETED

Trial details

NCT number: NCT00388089
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-12-01
Primary completion: 2007-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.